bupivacaine hydrochloride
Drug ingredientActive ShortageThis drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
Where It Comes From
42 FDA-registered drug labelers
A-S Medication Solutions
Abhilasha Pharma Pvt. Ltd.
Apex Healthcare Limited
Asclemed USA, Inc.
AX Pharmaceutical Corp
B. Braun Medical Inc.
Brookfield Pharmaceuticals, LLC.
Camber Pharmaceuticals, Inc.
Cambrex Karlskoga AB
Cardinal Health 107, LLC
DISHMAN CARBOGEN AMCIS LIMITED
Eugia US LLC
Excella GmbH & Co. KG
Fagron Inc
Fosun Pharma USA Inc.
Fresenius Kabi USA, LLC
Harman Finochem Limited
Henry Schein, Inc
HF Acquisition Co LLC, DBA HealthFirst
Hikma Pharmaceuticals USA Inc.
Hospira, Inc.
Huons Co., Ltd.
LETCO MEDICAL, LLC
Medical Purchasing Solutions, LLC
Medisca Inc.
Meitheal Pharmaceuticals Inc
Moehs Catalana SL
NorthStar RxLLC
ONESOURCE SPECIALTY PHARMA LIMITED
Pharma Source Direct, Inc.
Professional Compounding Centers of America
Professional Compounding Centers of America dba PCCA
ProPharma Distribution
Siegfried Evionnaz SA
Societa Italiana Medicinali Scandicci S.I.M.S., SrL
Solupharm Pharmazeutische Erzeugnisse GmbH
Somerset Therapeutics, LLC
Spectrum Laboratory Products, Inc.
Sportpharm LLC
Sportpharm, Inc. dba Sportpharm
Willow Birch Pharma, LLC
Xellia Pharmaceuticals USA LLC
Why It Matters
Sectors
Health
Downstream Uses
Appears in 19 drug and cosmetic product listings (FDA).
- •Bupivacaine Hydrochloride
- •Marcaine with Epinephrine
- •Bupivacaine Hydrochloride injection, solution
- •Bupivacaine HCl
- •Marcaine
- •Marcaine Spinal
- •Bupivacaine Hydrochloride and Epinephrine
- •Bupivicaine Hydrochloride
Show all 19
- •Sensorcaine MPF
- •Bupivacaine HCI AND Epinephrine
- •Sensorcaine
- •Bupivacine HCl
- •Marvona SUIK
- •Marvona-25 SUIK
- •Sensorcaine(R) (Bupivacaine HCI AND Epinephrine)
- •Bupivacaine Hydrochloride with Dextrose
- •Bupivacaine HCI
- •Bupivacaine Spinal
- •0.25% Bupivacaine HCl
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
Active Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
current
Bupivacaine Hydrochloride Injection
02/20/2018Available
current
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
02/20/2018Available
current
Bupivacaine Hydrochloride Injection
02/20/2018Unavailable
current
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
02/20/2018Unavailable
Chemical Identity
CAS18010-40-7
PubChem CID64737
DTXSIDDTXSID0030877
FormulaC18H29ClN2O
Mol. Weight324.9 g/mol
SMILESCCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl
Data Sources
647372026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/bupivacaine hydrochloride/cids/JSON
Archive: data/sources/pubchem_name/bupivacaine hydrochloride.json
CAS 18010-40-72026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 18010-40-72026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json